Apalutamide toxicity and tolerability: A real-world multicentre experience in metastatic hormone-sensitive prostate cancer (MHSPC) in the United Kingdom (UK).

被引：0
|
作者：
Ramamurthy, Sindhu
Elumalai, Thiraviyam
Pearson, Rachel
Bolnykh, Iakov
Muhammad-Afzal, Tehreem
Olukiran, Gbenro
Arora, Ananya
Bradley, Gay
Taft, Kate
Myint, Nayan Lin
Htike, Ei The
Ince, Will
Jiang, Xue Yan
机构：
[1] United Lincolnshire Hosp NHS Trust, Lincoln, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England
[3] Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[4] United Lincolnshire Hosp NHS Trust, Grantham, England
[5] Univ Cambridge, Sch Med, Cambridge, England
[6] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-5577-5578; 613-615-646-3281-7408-2638; 261-492-199; 130-3426-5390-2622; 130-3426-3529; 283-2494; 613-302-309; 6; 5; 4; 3; 2; 1917; 8;
D O I：
10.1200/JCO.2024.42.4_suppl.107
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review
    Raval, Amit D.
    Chen, Stephanie
    Littleton, Natasha
    Constantinovici, Niculae
    Goebell, Peter J.
    BJU INTERNATIONAL, 2025, 135 (03) : 408 - 421
  • [42] Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice
    Park, Kwonoh
    Kim, Jin Young
    Park, Inkeun
    Shin, Seong Hoon
    Lee, Hyo Jin
    Lee, Jae Lyun
    YONSEI MEDICAL JOURNAL, 2023, 64 (02) : 86 - 93
  • [43] Treatment guideline concordance for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in the United States in IRONMAN, the International Registry for Men with Advanced Prostate Cancer
    McManus, Hannah Dzimitrowicz
    Howard, Lauren
    Crowell, Kerri-Anne
    Hyslop, Terry
    Vinson, Jake
    Rathkopf, Dana E.
    Kantoff, Philip
    Mucci, Lorelei A.
    George, Daniel
    Stopsack, Konrad
    CANCER RESEARCH, 2024, 84 (06)
  • [44] Erstlinientherapie beim metastasierten hormonsensitiven Prostatakarzinom (mHSPC)First-line treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
    H. Rexer
    S. Feyerabend
    M. Graefen
    Forum, 2023, 38 (3) : 238 - 239
  • [45] Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
    Kenrick Ng
    Shievon Smith
    Jonathan Shamash
    Oncology and Therapy, 2020, 8 : 209 - 230
  • [46] Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
    Ng, Kenrick
    Smith, Shievon
    Shamash, Jonathan
    ONCOLOGY AND THERAPY, 2020, 8 (02) : 209 - 230
  • [47] Utilisation rates of treatment intensification for metastatic hormone sensitive prostate cancer (mHSPC) in England, UK
    Dodkins, J.
    Cook, A.
    Nossiter, J.
    Payne, H. A.
    Clarke, N. W.
    van der Meulen, J.
    Aggarwal, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S967 - S967
  • [48] Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide
    Lowentritt, Benjamin H.
    Du, Shawn
    Rossi, Carmine
    Muser, Erik
    Khilfeh, Ibrahim
    Kinkead, Frederic
    Korsiak, Jill
    Lefebvre, Patrick
    Pilon, Dominic
    Agarwal, Neeraj
    FUTURE ONCOLOGY, 2024, 20 (27) : 2005 - 2013
  • [49] Real-World Treatment Patterns and Survival Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: Insights From a Retrospective Cohort Study
    Tashkandi, Emad
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 419 - 428
  • [50] TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
    Pisano, Chiara
    Turco, Fabio
    Arnaudo, Elena
    Fea, Elena
    Vanella, Paola
    Ruatta, Fiorella
    Filippi, Roberto
    Brusa, Federica
    Prati, Veronica
    Vana, Federica
    Mennitto, Alessia
    Cattrini, Carlo
    Vignani, Francesca
    Dionisio, Rossana
    Icardi, Massimiliano
    Guglielmini, Pamela
    Buosi, Roberta
    Stevani, Ilaria
    Vormola, Roberto
    Numico, Gianmauro
    Depetris, Ilaria
    Comandone, Alessandro
    Gennari, Alessandra
    Rossi, Maura
    Airoldi, Mario
    Vellani, Giorgio
    Ortega, Cinzia
    Tucci, Marcello
    Di Maio, Massimo
    Buttigliero, Consuelo
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 56 - 67.e16
12345